BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Heptares 

1-3 Burtonhole Lane, Mill Hill

London    NW7 1AD  United Kingdom
Phone: 44-0-20-8906-7100 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Drug Discovery





 Company News
Heptares Technology Enables Breakthrough In Drug Discovery Collaboration With AstraZeneca PLC (AZN) 1/22/2015 10:23:02 AM
Heptares Adds Experts In Drug Discovery And Development To Its Board Of Directors 1/8/2015 9:02:15 AM
Heptares To Present At Upcoming East/West CEO Conference 1/6/2015 1:42:14 PM
Heptares Extends Global Patent Protection For GPCR-Focused Drug Discovery Platform With Grant Of Core Patents In The United States 12/15/2014 7:34:57 AM
Heptares Orphan Disease Programme Awarded Grant From The UK Biomedical Catalyst 11/20/2014 1:14:35 PM
Heptares First-In-Class Selective Muscarinic Agonists Chosen As One Of Top Neuroscience Projects To Watch 11/17/2014 11:36:36 AM
Heptares To Present On Structure-Based Drug Design Using G Protein-Coupled Receptors At Inaugural Chemistry & Engineering News Virtual Symposium 9/16/2014 9:17:33 AM
Heptares To Present At CNS Partnering & Deal-Making And Biopharm America 9/10/2014 8:35:28 AM
Heptares Release: Innovative Technology Enables First Crystal Structure Of A Class C GPCR Drug Target (mGLU5) Transmembrane Domain To Be Determined 7/17/2014 10:30:48 AM
Heptares Announces Publication In Nature Of First Structure Of Metabotropic Glutamate Receptor 5 Transmembrane Domain 7/7/2014 9:05:47 AM
12345